New Parkinson’s drug approved in the US: What does it do differently?

Ynetnews Культура

The FDA approved a new once-daily Parkinson’s pill in the dopamine agonist class, designed to selectively target receptors studied for decades; in trials, AbbVie’s drug improved movement and daily functioning